HK1051690A1 - Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain. - Google Patents
Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.Info
- Publication number
- HK1051690A1 HK1051690A1 HK03103988A HK03103988A HK1051690A1 HK 1051690 A1 HK1051690 A1 HK 1051690A1 HK 03103988 A HK03103988 A HK 03103988A HK 03103988 A HK03103988 A HK 03103988A HK 1051690 A1 HK1051690 A1 HK 1051690A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- benzamidederivatives
- ylidene
- piperidin
- hydroxyphenyl
- pain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0001207A SE0001207D0 (sv) | 2000-04-04 | 2000-04-04 | Novel compounds |
PCT/SE2001/000707 WO2001074804A1 (fr) | 2000-04-04 | 2001-03-30 | Derives d'hydroxyphenyl-piperidine-4-ylidene-methyl-benzamide utilises comme analgesiques |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1051690A1 true HK1051690A1 (en) | 2003-08-15 |
Family
ID=20279146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03103988A HK1051690A1 (en) | 2000-04-04 | 2003-06-05 | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain. |
Country Status (29)
Country | Link |
---|---|
US (1) | US6756387B2 (fr) |
EP (1) | EP1282616B1 (fr) |
JP (1) | JP2003529596A (fr) |
KR (1) | KR20020084285A (fr) |
CN (1) | CN1185228C (fr) |
AR (1) | AR027983A1 (fr) |
AT (1) | ATE269324T1 (fr) |
AU (1) | AU2001244981A1 (fr) |
BR (1) | BR0109816A (fr) |
CA (1) | CA2404386A1 (fr) |
CZ (1) | CZ20023289A3 (fr) |
DE (1) | DE60103889T2 (fr) |
DK (1) | DK1282616T3 (fr) |
EE (1) | EE200200571A (fr) |
ES (1) | ES2220748T3 (fr) |
HK (1) | HK1051690A1 (fr) |
HU (1) | HUP0300427A2 (fr) |
IL (1) | IL151890A0 (fr) |
IS (1) | IS6575A (fr) |
MX (1) | MXPA02009757A (fr) |
NO (1) | NO20024775L (fr) |
NZ (1) | NZ522142A (fr) |
PL (1) | PL357780A1 (fr) |
PT (1) | PT1282616E (fr) |
RU (1) | RU2002125495A (fr) |
SE (1) | SE0001207D0 (fr) |
SK (1) | SK14232002A3 (fr) |
WO (1) | WO2001074804A1 (fr) |
ZA (1) | ZA200207968B (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW548271B (en) | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
SE0101765D0 (sv) | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0101768D0 (sv) | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0101769D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0101770D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0101771D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0101766D0 (sv) | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0101773D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0101767D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
SE0103313D0 (sv) * | 2001-10-03 | 2001-10-03 | Astrazeneca Ab | Novel compounds |
AU2003214800A1 (en) | 2002-01-02 | 2003-07-24 | Ardent Pharmaceuticals, Inc. | Method of treating sexual dysfunctions with delta opioid receptor agonist compounds |
US8476280B2 (en) * | 2002-05-09 | 2013-07-02 | Versi Group, Llc | Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
SE0203301D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
SE0300105D0 (sv) * | 2003-01-16 | 2003-01-16 | Astrazeneca Ab | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof |
SE0300104D0 (sv) * | 2003-01-16 | 2003-01-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
SE0300103D0 (sv) * | 2003-01-16 | 2003-01-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
SE0300987D0 (sv) * | 2003-04-03 | 2003-04-03 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
KR20060010811A (ko) * | 2003-05-16 | 2006-02-02 | 아스트라제네카 아베 | 디아릴메틸리덴 피페리딘 유도체, 그의 제조 및 그의 용도 |
SE0301445D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
SE0301442D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations therof and uses thereof |
SE0301443D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
SE0301441D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
EA015491B1 (ru) * | 2003-06-27 | 2011-08-30 | Янссен Фармацевтика Н.В. | ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ |
SE0400026D0 (sv) * | 2004-01-09 | 2004-01-09 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
SE0402485D0 (sv) | 2004-10-13 | 2004-10-13 | Astrazeneca Ab | Polymorph of N,N-Diethyl-4-(3-Fluorophenyl-Piperidin-4-Ylidene-Methyl)-Benzamide Hydrochloride salt |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2898339A (en) | 1957-07-29 | 1959-08-04 | Wm S Merrell Co | N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine |
US4581171A (en) | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
US4816586A (en) | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
US5140029A (en) | 1989-01-09 | 1992-08-18 | Janssen Pharmaceutica N.V. | 2-aminopyrimidinone derivatives |
US4939137A (en) | 1989-06-28 | 1990-07-03 | Ortho Pharmaceutical Corporation | Ring-fused thienopyrimidinedione derivatives |
US5683998A (en) | 1991-04-23 | 1997-11-04 | Toray Industries, Inc. | Tricyclic triazolo derivatives, processes for producing the same and the uses of the same |
US5574159A (en) | 1992-02-03 | 1996-11-12 | Delta Pharmaceuticals, Inc. | Opioid compounds and methods for making therefor |
GB9202238D0 (en) | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
US5985880A (en) * | 1996-06-05 | 1999-11-16 | Delta Pharmaceuticals | Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
SE9504661D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
TW548271B (en) * | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
AU2009799A (en) * | 1997-12-24 | 1999-07-19 | Ortho-Mcneil Pharmaceutical, Inc. | 4-(aryl(piperidin-4-yl)) aminobenzamides which bind to the delta-opioid receptor |
-
2000
- 2000-04-04 SE SE0001207A patent/SE0001207D0/xx unknown
-
2001
- 2001-03-28 AR ARP010101477A patent/AR027983A1/es not_active Application Discontinuation
- 2001-03-30 HU HU0300427A patent/HUP0300427A2/hu unknown
- 2001-03-30 MX MXPA02009757A patent/MXPA02009757A/es unknown
- 2001-03-30 KR KR1020027013207A patent/KR20020084285A/ko not_active Application Discontinuation
- 2001-03-30 PT PT01918113T patent/PT1282616E/pt unknown
- 2001-03-30 DK DK01918113T patent/DK1282616T3/da active
- 2001-03-30 AU AU2001244981A patent/AU2001244981A1/en not_active Abandoned
- 2001-03-30 BR BR0109816-0A patent/BR0109816A/pt not_active IP Right Cessation
- 2001-03-30 IL IL15189001A patent/IL151890A0/xx unknown
- 2001-03-30 US US10/240,038 patent/US6756387B2/en not_active Expired - Fee Related
- 2001-03-30 AT AT01918113T patent/ATE269324T1/de not_active IP Right Cessation
- 2001-03-30 CZ CZ20023289A patent/CZ20023289A3/cs unknown
- 2001-03-30 PL PL01357780A patent/PL357780A1/xx not_active Application Discontinuation
- 2001-03-30 EE EEP200200571A patent/EE200200571A/xx unknown
- 2001-03-30 SK SK1423-2002A patent/SK14232002A3/sk not_active Application Discontinuation
- 2001-03-30 NZ NZ522142A patent/NZ522142A/en unknown
- 2001-03-30 EP EP01918113A patent/EP1282616B1/fr not_active Expired - Lifetime
- 2001-03-30 WO PCT/SE2001/000707 patent/WO2001074804A1/fr active IP Right Grant
- 2001-03-30 RU RU2002125495/04A patent/RU2002125495A/ru not_active Application Discontinuation
- 2001-03-30 CN CNB018105939A patent/CN1185228C/zh not_active Expired - Fee Related
- 2001-03-30 DE DE60103889T patent/DE60103889T2/de not_active Expired - Fee Related
- 2001-03-30 ES ES01918113T patent/ES2220748T3/es not_active Expired - Lifetime
- 2001-03-30 CA CA002404386A patent/CA2404386A1/fr not_active Abandoned
- 2001-03-30 JP JP2001572494A patent/JP2003529596A/ja active Pending
-
2002
- 2002-09-30 IS IS6575A patent/IS6575A/is unknown
- 2002-10-03 NO NO20024775A patent/NO20024775L/no not_active Application Discontinuation
- 2002-10-03 ZA ZA200207968A patent/ZA200207968B/en unknown
-
2003
- 2003-06-05 HK HK03103988A patent/HK1051690A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20024775D0 (no) | 2002-10-03 |
CA2404386A1 (fr) | 2001-10-11 |
ATE269324T1 (de) | 2004-07-15 |
PT1282616E (pt) | 2004-10-29 |
NO20024775L (no) | 2002-12-03 |
WO2001074804A1 (fr) | 2001-10-11 |
US20030187022A1 (en) | 2003-10-02 |
DE60103889T2 (de) | 2005-08-25 |
ES2220748T3 (es) | 2004-12-16 |
EP1282616B1 (fr) | 2004-06-16 |
KR20020084285A (ko) | 2002-11-04 |
ZA200207968B (en) | 2004-04-07 |
PL357780A1 (en) | 2004-07-26 |
AU2001244981A1 (en) | 2001-10-15 |
EE200200571A (et) | 2004-04-15 |
NZ522142A (en) | 2004-06-25 |
SK14232002A3 (sk) | 2003-06-03 |
IS6575A (is) | 2002-09-30 |
JP2003529596A (ja) | 2003-10-07 |
CN1185228C (zh) | 2005-01-19 |
US6756387B2 (en) | 2004-06-29 |
DK1282616T3 (da) | 2004-09-20 |
MXPA02009757A (es) | 2003-05-27 |
RU2002125495A (ru) | 2004-04-10 |
SE0001207D0 (sv) | 2000-04-04 |
CZ20023289A3 (cs) | 2003-03-12 |
AR027983A1 (es) | 2003-04-23 |
HUP0300427A2 (hu) | 2003-06-28 |
EP1282616A1 (fr) | 2003-02-12 |
IL151890A0 (en) | 2003-04-10 |
BR0109816A (pt) | 2003-01-21 |
DE60103889D1 (de) | 2004-07-22 |
CN1432009A (zh) | 2003-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1051690A1 (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain. | |
IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
GB0028264D0 (en) | Well treatment | |
AP2004003002A0 (en) | azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease. | |
GB0028269D0 (en) | Well treatment | |
ZA200202449B (en) | Use of retigabin for treating neuropathic pain. | |
MXPA03001419A (es) | Combinacion terapeutica de un inhibidor de la proteina de transferencia de esteres de colesterol y atorvastatina. | |
PL362855A1 (en) | Improved treatment | |
EG25829A (en) | Novel treatment | |
GB0030845D0 (en) | Novel treatment | |
ZA200307475B (en) | Carbamate compounds for use in the treatment of pain. | |
HK1051692A1 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain. | |
IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
ZA200105690B (en) | Novel treatment. | |
GB0001710D0 (en) | Therapeutic treatment | |
HK1041661A1 (en) | Electromedical treatment applicator. | |
MXPA03004017A (es) | Metodo para el tratamiento de inflamacion. | |
AU2096002A (en) | Therapeutic treatment | |
GB0029524D0 (en) | Disease treatment | |
HK1056828A1 (en) | Treatment of burns. | |
GB0031321D0 (en) | Treatment | |
GB0029125D0 (en) | Novel treatment | |
GB0025655D0 (en) | Sludge treatment | |
ZA200304439B (en) | Therapeutic treatment. | |
GB0019728D0 (en) | Novel treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20080330 |